Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients

被引：2

作者：

Van den Eynde, Eva ^{[1
]}

Curto, Jordi ^{[1
]}

Ferrer, Elena ^{[1
]}

Imaz, Arkaitz ^{[1
]}

Saumoy, Maria ^{[1
]}

Di Yacovo, Silvana ^{[1
]}

Vila, Antonia ^{[1
]}

Podzamczer, Daniel ^{[1
]}

机构：

[1] Hosp Univ Bellvitge, Antigua Escuela Enfermeria, Infect Dis Serv, HIV Unit, Barcelona 08907, Spain

来源：

AIDS | 2015年 / 29卷 / 08期

关键词：

THERAPY;

D O I：

10.1097/QAD.0000000000000643

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We investigated kidney function outcome in 24 chronic hepatitis C genotype 1 patients coinfected with HIV receiving telaprevir in a single tertiary care hospital in Spain. A statistically significant median (interquartile range) decrease in estimated glomerular filtration rate (eGFR, ml/min/1.73 m(2)) relative to baseline [93.6 (73.0-109.0)] was seen at weeks 4 [86.5 (34.0-112.0), P=0.014], 8 [90.0 (49.0-111.0), P=0.026] and 12 [89.5 (54.0-113.0), P=0.017]. These changes reversed after telaprevir discontinuation. Patients presenting an eGFR decrease had a higher risk of haematological toxicity.

引用

页码：977 / 979

页数：3

共 50 条

[41] Estimated Glomerular Filtration Rate in Patients with Aplastic Anemia
Hori, Daiki
Kobayashi, Ryoji
Miyake, Noel
Sano, Hirozumi
Suzuki, Daisuke
Kobayashi, Kunihiko
PEDIATRIC BLOOD & CANCER, 2017, 64 : S100 - S100
[42] Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
Bedimo, R.
Ghurani, R.
Nsuami, M.
Turner, D.
Kvanli, M-B
Brown, G.
Margolis, D.
HIV MEDICINE, 2006, 7 (08) : 530 - 536
[43] Hepatitis C virus-HIV-coinfected patients and liver transplantation
Kardashian, Ani A.
Price, Jennifer C.
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (03) : 276 - 285
[44] Hepatitis C viral kinetics during treatment of hepatitis C virus/HIV coinfected patients
Zeremski, Marija
Talal, Andrew H.
CURRENT OPINION IN HIV AND AIDS, 2007, 2 (06) : 489 - 495
[45] Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/hepatitis C virus coinfected women
French, Audrey L.
Grennan, Dara
Daubert, Elizabeth
Seaberg, Eric C.
Peters, Marion
Augenbraun, Michael
Fischl, Margaret
Kassaye, Seble
Franco, Ricardo
Kuniholm, Mark
Adimora, Adaora A.
Workowski, Kimberly
Weber, Kathleen M.
AIDS, 2021, 35 (09) : 1433 - 1438
[46] Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients
Bollepalli, Srigayatri
Mathieson, Kathleen
Bay, Curt
Hillier, Amy
Post, John
Van Thiel, David H.
Nadir, Abdul
SEXUALLY TRANSMITTED DISEASES, 2007, 34 (06) : 367 - 370
[47] Liver fibrosis stage found with liver biopsy or transient elastography in HIV-hepatitis C-coinfected patients
Roca, B.
Torres, V.
Resino, E.
Mendoza, M. A.
HIV MEDICINE, 2013, 14 : 69 - 69
[48] The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
Linas, Benjamin P.
Barter, Devra M.
Leff, Jared A.
DiLorenzo, Madeline
Schackman, Bruce R.
Horsburgh, Charles R.
Assoumou, Sabrina A.
Salomon, Joshua A.
Weinstein, Milton C.
Kim, Arthur Y.
Freedberg, Kenneth A.
AIDS, 2014, 28 (03) : 365 - 376
[49] Assessment of glomerular filtration rate in hepatitis C virus patients after reaching sustained virologic response
Campos, N. R. R.
Castro, R. Q.
Torres, P. L.
Arriero, G. M.
Ron, L. M.
Vidal, D. V.
Lucas, C. V.
Palacios, M. J.
Cuenllas, B. A.
Plaza, F. J.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S727 - S727
[50] Change in Estimated Glomerular Filtration Rate After Direct-Acting Antiviral Treatment in Chronic Hepatitis C Patients
Dashjamts, Gantogtokh
Ganzorig, Amin-Erdene
Tsedendorj, Yumchinsuren
Daramjav, Dolgion
Khayankhyarvaa, Enkhmend
Ulziitsogt, Bolor
Nergui, Otgongerel
Dondov, Ganchimeg
Badamjav, Tegshjargal
Lonjid, Tulgaa
Huang, Chung-Feng
Liang, Po-Cheng
Batsaikhan, Batbold
Dai, Chia-Yen
DISEASES, 2025, 13 (02)

← 1 2 3 4 5 →